US biopharmaceutical company licenses Monash University 'superbug' drug discovery

L-R Associate Professor Tony Velkov, Professor Philip Thompson, Professor Jian Li, Dr Kade Roberts, Professor Roger Nation
L-R Associate Professor Tony Velkov, Professor Philip Thompson, Professor Jian Li, Dr Kade Roberts, Professor Roger Nation

Monash University has granted an exclusive license of its portfolio of proprietary synthetic polymyxin antibiotics to Qpex Biopharma, a US-based biopharmaceutical company focused on developing new antibiotics to combat the growing threat of global antimicrobial resistance. The antibiotics were developed by a team led by Monash BDI's Professor Jian Li, and the story was covered in the Pittsburgh Post-GazetteSpoke and First Word Pharma.

Read the full press release here.